549 related articles for article (PubMed ID: 28704199)
1. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease.
Zhang Y; Chen X; Zhao Y; Ponnusamy M; Liu Y
Rev Neurosci; 2017 Nov; 28(8):861-868. PubMed ID: 28704199
[TBL] [Abstract][Full Text] [Related]
2. Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system.
Lee MJ; Lee JH; Rubinsztein DC
Prog Neurobiol; 2013 Jun; 105():49-59. PubMed ID: 23528736
[TBL] [Abstract][Full Text] [Related]
3. The Ubiquitin System in Alzheimer's Disease.
Harris LD; Jasem S; Licchesi JDF
Adv Exp Med Biol; 2020; 1233():195-221. PubMed ID: 32274758
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and the autophagic-lysosomal system.
Chung KM; Hernández N; Sproul AA; Yu WH
Neurosci Lett; 2019 Apr; 697():49-58. PubMed ID: 29758300
[TBL] [Abstract][Full Text] [Related]
5. Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis.
Cao J; Zhong MB; Toro CA; Zhang L; Cai D
Neurosci Lett; 2019 Jun; 703():68-78. PubMed ID: 30890471
[TBL] [Abstract][Full Text] [Related]
6. Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.
Hong L; Huang HC; Jiang ZF
Neurol Res; 2014 Mar; 36(3):276-82. PubMed ID: 24512022
[TBL] [Abstract][Full Text] [Related]
7. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies.
Ji XR; Cheng KC; Chen YR; Lin TY; Cheung CHA; Wu CL; Chiang HC
FASEB J; 2018 Mar; 32(3):1375-1387. PubMed ID: 29127191
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer's Disease.
Zhao Y; Zhang Y; Zhang J; Zhang X; Yang G
Curr Neuropharmacol; 2020; 18(8):720-739. PubMed ID: 31934838
[TBL] [Abstract][Full Text] [Related]
10. The Implications of Autophagy in Alzheimer's Disease.
Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.
Gadhave K; Bolshette N; Ahire A; Pardeshi R; Thakur K; Trandafir C; Istrate A; Ahmed S; Lahkar M; Muresanu DF; Balea M
J Cell Mol Med; 2016 Jul; 20(7):1392-407. PubMed ID: 27028664
[TBL] [Abstract][Full Text] [Related]
12. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.
van Leeuwen FW; Hol EM; Fischer DF
J Alzheimers Dis; 2006; 9(3 Suppl):319-25. PubMed ID: 16914870
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of Tom1 in relation to protein degradation systems in Alzheimer's disease.
Makioka K; Yamazaki T; Takatama M; Ikeda M; Murayama S; Okamoto K; Ikeda Y
J Neurol Sci; 2016 Jun; 365():101-7. PubMed ID: 27206884
[TBL] [Abstract][Full Text] [Related]
14. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
[TBL] [Abstract][Full Text] [Related]
15. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
[TBL] [Abstract][Full Text] [Related]
16. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.
Sulistio YA; Heese K
Mol Neurobiol; 2016 Mar; 53(2):905-931. PubMed ID: 25561438
[TBL] [Abstract][Full Text] [Related]
17. Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.
Gorantla NV; Chinnathambi S
J Mol Neurosci; 2018 Nov; 66(3):356-368. PubMed ID: 30267382
[TBL] [Abstract][Full Text] [Related]
18. Effects of corticosterone and amyloid-beta on proteins essential for synaptic function: implications for depression and Alzheimer's disease.
Wuwongse S; Cheng SS; Wong GT; Hung CH; Zhang NQ; Ho YS; Law AC; Chang RC
Biochim Biophys Acta; 2013 Dec; 1832(12):2245-56. PubMed ID: 23928361
[TBL] [Abstract][Full Text] [Related]
19. Tau Clearance Mechanisms.
Tang M; Harrison J; Deaton CA; Johnson GVW
Adv Exp Med Biol; 2019; 1184():57-68. PubMed ID: 32096028
[TBL] [Abstract][Full Text] [Related]
20. Molecular Insight into the Crosstalk of UPS Components and Alzheimer's Disease.
Al Mamun A; Rahman MM; Zaman S; Munira MS; Uddin MS; Rauf A; Banu N; Ashraf GM
Curr Protein Pept Sci; 2020; 21(12):1193-1201. PubMed ID: 32964822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
